RR-EAE mimics the initial course of multiple sclerosis symptoms seen in patients, and gained face validity despite limited availability of data in literature.

In the RR-EAE model implemented at Neurofit, the clinical disease score is very pronounced (complete paralysis) but still responds very well to immunosuppressant drugs.

This test is cost effective and has a short turnaround time. For more information please download our free white paper.